Index your Journal on RJRIndex - A product by ResearchJournalRank.com Index Now
34,158+ Journals Indexed Journal Suggester  |  Compare Journals
Home Frontiers in Bioscience - Landmark

Frontiers in Bioscience - Landmark

Q1 Journal Open Access Journal
Country
Hong Kong
Asiatic Region
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
Medicine (miscellaneous) Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous) Q2
Immunology and Microbiology (miscellaneous) Q2
Publisher
SJR 2025
0.915
Q1
SJR Score
H-Index
174
Citations / Doc (2yr)
4.02
Total Docs. (latest)
380
Total Citations (3yr)
4,466
Publication type
Journals
ISSN
27686701, 27686698
Coverage
1987, 1996-2026
Journal Rank
#5,627

Subject Categories

Medicine (miscellaneous) Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous) Q2
Immunology and Microbiology (miscellaneous) Q2

Detailed Metrics

Total Docs. (latest) 380
Total Docs. (3 years) 1,133
Total Refs. 28,896
Total Citations (3 years) 4,466
Citable Docs. (3 years) 1,119
Citations / Doc. (2 years) 4.02
Ref. / Doc. 76.04
% Female 47.7%

Metrics Visualization

Latest year data vs 3-year cumulative figures

Publication & Citation Trend

Loading trend data from Crossref...

Top 10 Most Cited Articles

Loading articles...

Journal Information

SJR0.915
Best QuartileQ1
H Index174
ISSN27686701, 27686698
PublisherIMR Press Limited
CountryHong Kong
RegionAsiatic Region
Coverage1987, 1996-2026
Open AccessYes
TypeJournal
Rank#5,627

Similar Journals

View all Biochemistry, Genetics and Molecular Biology journals

Embed This Journal

Add this journal's ranking badge to your website:

<iframe src="https://researchjournalrank.com/widget.php?id=6846" style="border:1px solid #e0e0e0;border-radius:8px;width:100%;max-width:320px;height:200px" frameborder="0"></iframe>
Preview:

Researcher Reviews

Write a Review

No reviews yet for this journal.

Be the first to share your experience!

Share Your Experience

Your review will be published after moderation. Email will not be displayed publicly.